Anxiety in Older Adults: Why It Gets Missed and What Treatment Looks Like

Last reviewed: 08/07/2026

Reviewed by: Dr. Kiesa Kelly

A woman in her seventies goes to her doctor because she is not sleeping, her chest feels tight in the mornings, and she has started losing the thread in conversations. She has a cardiac workup. She has bloodwork. Her family begins watching her more closely for signs of something neurological. Nobody asks whether she is anxious, and she does not volunteer it, because in her account of herself she is not an anxious person — she is a person whose body has started doing strange things.

That sequence is common enough to be its own clinical problem. Anxiety in later life is described in the research literature as under-recognized and undertreated, and the reasons are specific rather than vague: it presents differently, it overlaps with real medical illness, and the tools most likely to catch it were not built with this age group in mind. All three are addressable, and evidence-based therapy for anxiety works well at this age — which makes the recognition gap the expensive part.

In this article, you'll learn:

• What the evidence actually says about how common late-life anxiety is

• Why physical symptoms, not worry, are usually what gets reported

• Where standard anxiety screeners fall short in older adults

• How anxiety and memory concerns relate — and where they don't

• What treatment outcomes look like at this age

• What to bring to an appointment, and what to ask

The short answer: what late-life anxiety is

Late-life anxiety is not a separate diagnosis. It is the same set of anxiety disorders — generalized anxiety, panic, phobias, social anxiety — appearing in a body and a life stage that change how they look from the outside.

The honest prevalence picture is more interesting than the one that usually circulates. Contrary to the stereotype of the anxious elderly relative, a 2024 review in Psychiatric Clinics of North America states plainly that anxiety disorders are less common in older adults than in younger adults, affecting roughly one in ten [1]. Surveys that measure anxiety symptoms rather than diagnosable disorders return much higher numbers — a 2025 global meta-analysis put pooled symptom prevalence at 28%, with the measurement tool itself significantly affecting the estimate [2]. Both figures are real; they are counting different things, and marketing pages aimed at older adults tend to quote the larger one without saying so.

What makes late-life anxiety serious is not frequency. It is that these disorders tend to be unremitting — they do not typically resolve on their own — and they carry elevated risk of depression, cognitive and functional decline, physical health problems, higher healthcare use, and suicide [1]. A condition that is somewhat less common but far less likely to go away by itself is a strong argument for looking, not a weak one.

📊 Key takeaway: Anxiety disorders are less common after 65, not more. What distinguishes them at this age is that they rarely remit without treatment.

Three things that get this wrong

"Some anxiety is just part of getting older." Worry that is proportionate to real circumstances — illness, loss, a shrinking social world — is not a disorder. But persistent anxiety that interferes with sleep, eating, activity, or relationships is not a developmental stage, and the research does not support treating it as one. Framing it as normal aging is one of the reliable routes to it going untreated.

"If it were anxiety, she'd say she was worried." Many older adults will deny psychological symptoms while endorsing the same experience in different language — on edge, unsettled, cannot get comfortable, something is wrong. The absence of the word "anxious" is not the absence of anxiety, which is part of why structured screening asks in several directions rather than waiting for one word.

"It's too late for therapy to help." This is contradicted directly by the treatment data below, which is the strongest single reason to read the rest of this article.

Why it gets missed

The symptoms arrive as the body, not as worry

The most common route to a missed diagnosis is that the presenting complaint is physical. Sleep disturbance, muscle tension, restlessness, chest tightness, gastrointestinal upset, shortness of breath, difficulty concentrating — these are all physical symptoms of anxiety, and they are also the symptoms of a dozen other things worth ruling out.

Consider how this plays out over six months. In March you mention poor sleep at a routine visit and get advice about sleep hygiene. In May the chest tightness leads to an EKG, which is normal, and you are relieved and mildly embarrassed. In July you mention the stomach trouble to a different provider, who has not seen the other two notes in context. Each conversation is reasonable on its own. Nobody has yet asked the question that connects them, because each symptom got routed to the system that owns it.

Medical conditions and medications that genuinely look like anxiety

This is not just a recognition problem — it is a real differential. Thyroid dysfunction, cardiac and respiratory conditions, and the effects of several common medication classes can all produce symptoms indistinguishable from anxiety on presentation. Polypharmacy makes this harder, not easier, because the interaction picture grows with every added prescription.

The clinical implication runs both directions. Anxiety should not be assumed before medical causes are considered, and it should not be dismissed once they are excluded. Both errors are common, and the second one is the quieter of the two.

The screener problem

Here is a specific, concrete reason cases get missed that most consumer pages never mention.

The GAD-7 is the most widely used brief anxiety screener in primary care, originally validated with a cut point of 10 or above for identifying generalized anxiety disorder [3]. It has also been validated in older people — but that validation study concluded that the recommended cut points for the GAD-7 and GAD-2 should be lowered for the elderly general population [4].

Read that consequence carefully. An older adult can complete the same screener that would flag a 40-year-old, score below the standard threshold, and be told the result is reassuring — when the threshold itself is the wrong one for their age group. Instruments designed specifically for this population exist, including the Geriatric Anxiety Inventory [5]. A screener is a starting point for a conversation, not a diagnosis, and this is one of the clearest illustrations of why.

🩺 Key takeaway: A standard-threshold GAD-7 score can look reassuring in an older adult and still be a false negative. The validation evidence says the cut point should be lower at this age.

"Is this anxiety, or is it my memory?"

This question comes up in nearly every conversation on this topic, usually from a family member, and it deserves a precise answer rather than a reassuring one.

The relationship between anxiety and memory in older adults is real but narrower than it is usually described. Anxiety is consistently associated with increased subjective memory complaints — how much a person notices and worries about lapses. The findings on objective memory performance are mixed, with some studies showing an inverse relationship and others showing none [6]. The link also runs the other way: perceived memory decline predicts later anxiety symptoms, so worry about memory can be a consequence of noticing changes, not only a cause of them [6].

What this does not mean is that new cognitive change can be attributed to anxiety and left there. Sorting out whether concentration and memory trouble after 50 reflects anxiety, depression, medication, hormonal change, lifelong undiagnosed ADHD, or early cognitive decline is its own careful process, and we go through it in cognitive changes after 50: ADHD or dementia?. Rather than duplicate that here, the point to carry from this article is the narrower one: anxiety reliably changes how memory feels, and any new change in how memory performs still needs a proper look.

How it is assessed

What an evaluation looks at

A good adult anxiety evaluation at this age does four things. It takes a symptom history that asks about physical experience rather than waiting for the word "worry." It reviews medical conditions and the full medication list, including over-the-counter and supplements. It screens for depression as well as anxiety, because the two co-occur frequently and the treatment emphasis differs — the PHQ-9 is commonly used alongside an anxiety measure. And it establishes a timeline: lifelong anxiety that has worsened is a different clinical picture from anxiety that began at 71, and the second one raises the index of suspicion for a medical or medication contributor.

The general shape of that process is covered in anxiety assessment for adults; what changes at this age is the weight given to the medical and medication review, and the caution about screener thresholds.

What to bring to the appointment

• A complete medication list, including over-the-counter drugs, sleep aids, and supplements

• A rough timeline: when this started, what it looked like at the beginning, what has changed

• The physical symptoms, written down, even the ones that seem unrelated

• Any recent test results — cardiac, thyroid, bloodwork — so they do not get repeated

• If a family member has noticed something you have not, bring them or bring their account

Four questions worth asking:

• Do you screen for anxiety directly, and which instrument do you use with older adults?

• How will you tell anxiety apart from a medication effect or a medical cause?

• Do you assess for depression at the same time?

• What would you recommend first — therapy, medication, or both — and why for me specifically?

📋 Key takeaway: The medication list and the timeline do more diagnostic work at this age than any symptom checklist. Bring both.

What treatment looks like

What the research shows

This is where the "too late for therapy" idea comes apart.

A 2026 systematic review and meta-analysis examined remission, response, attrition, and relapse across treatments for anxiety disorders in adults aged 60 and over. It found approximately 54% diagnostic remission after cognitive behavioral therapy compared with about 36% after pharmacotherapy, with treatment response of 53% for CBT and 62% for medication — though the authors note that definitions of "response" varied widely across studies. Relapse after CBT was around 33%, and attrition around 18% for both CBT and medication. The authors concluded the results suggest potential superiority of CBT as a first-line treatment for late-life anxiety [7]. That is consistent with general guidance for adults, which positions psychological therapy as a first-line option for generalized anxiety disorder [10].

The earlier evidence points the same way. A randomized clinical trial of 134 older adults with generalized anxiety disorder in primary care found CBT produced greater improvement in worry, depressive symptoms, and general mental health than enhanced usual care [8]. A meta-analysis of randomized trials of CBT for anxiety in older people confirmed effectiveness overall, while noting explicitly that the small number and modest quality of available studies limits how confident anyone should be in the precise size of the effect [9]. That caveat is worth stating rather than smoothing over — the direction of the evidence is clear, the magnitude is less settled.

Our CBT for anxiety in Tennessee page covers what that treatment actually involves session to session.

What progress looks like

Most CBT for anxiety runs in a defined course rather than open-ended, and progress usually shows up in what a person does before it shows up in how they feel — sleeping through, resuming a canceled activity, driving somewhere avoided. The relapse figure above is the practical argument for planning the ending as deliberately as the beginning: a booster schedule and a written plan for early warning signs belong in the conversation from the start, not after a setback.

🔑 Key takeaway: In adults 60 and over, CBT achieved roughly 54% diagnostic remission versus 36% for medication. About a third relapsed, which makes a booster plan part of the treatment, not an afterthought.

Access: telehealth, cost, and getting started

Telehealth removes several of the specific barriers that keep older adults out of treatment — driving after dark, arranging transportation, weather, mobility, and the energy cost of a trip that ends up being 50 minutes of care and two hours of logistics. We work telehealth-first across Tennessee, with an in-person option at our Nashville office.

On payment, we want to be direct rather than vague, because vagueness on this costs people appointments. We do not bill Medicare. Care with us is self-pay. If you have Medicare, the rules governing what happens when you see a provider who does not bill Medicare are different from ordinary out-of-network commercial coverage, and we would rather you ask us about your specific situation before you book than assume either way — get in touch and we will tell you plainly what to expect.

When to get evaluated

Consider an evaluation if physical symptoms have been worked up without a clear cause and the pattern has persisted; if sleep, appetite, activity, or relationships have narrowed over months; if a family member has noticed a change you have been explaining away; if anxiety that was always present has grown since a health event, a loss, or a medication change; or if you have been told a screener was normal and still do not feel right.

You do not need to arrive with the right label. What an evaluation gives you is a specific account of what is driving what — and at this age, with anxiety that rarely lifts on its own and treatment that works, that account is worth having.

🧭 Key takeaway: A normal screener and a normal cardiac workup are not the same as an answer. Persistent symptoms with no clear cause are a reason to ask the anxiety question directly.

Anxiety running the show?

Evidence-based therapy can turn the volume down on anxiety — a clinician can help you find the approach that fits your life rather than a one-size-fits-all plan.

Schedule an anxiety consultation →

Frequently Asked Questions

Why does anxiety get missed in older adults?

Mostly because of how it arrives. Older adults are more likely to bring a doctor physical complaints such as sleep trouble, chest tightness, restlessness, or stomach problems than to describe worry, and those symptoms overlap with real medical conditions and medication effects that reasonably get investigated first. Widely used screeners also perform differently in this age group, so a score that looks reassuring can be misleading.

Is anxiety more common in older adults than in younger adults?

No, and this is a common misconception. Reviews of the research are explicit that, contrary to ageist stereotypes, anxiety disorders are less common in later life than in younger adulthood. Roughly one in ten older adults is affected. What makes late-life anxiety serious is not how common it is but that it tends to be unremitting, meaning it rarely resolves on its own without treatment.

Can anxiety look like memory loss?

It can affect how memory feels more reliably than how memory performs. Anxiety is consistently linked to increased subjective memory complaints in older adults, while findings on objective memory testing are mixed. That distinction matters clinically, because someone can be genuinely distressed about their memory and still perform in the expected range. Any new cognitive change still deserves a proper evaluation rather than an assumption.

Does therapy work for anxiety later in life?

Yes. A 2026 systematic review and meta-analysis of treatments for anxiety disorders in adults 60 and over found about 54% diagnostic remission after cognitive behavioral therapy compared with about 36% after medication, and the authors concluded the results suggest CBT may be superior as a first-line treatment. Roughly a third of people relapsed after CBT, so booster sessions and a relapse plan are worth discussing.

Does the GAD-7 work for older adults?

It has been validated in older people, but a validation study found the standard cut points for the GAD-7 and GAD-2 should be lowered for the elderly general population. In practice that means a score below the usual threshold does not rule anxiety out at this age. A screener is a starting point for a conversation, never a diagnosis, and this is one of the clearer examples of why.

About the Author

Dr. Kiesa Kelly is a licensed clinical psychologist and the founder of ScienceWorks Behavioral Healthcare. Her background includes more than 20 years of experience in psychological assessment and evidence-based treatment, with clinical training at the University of Chicago, Vanderbilt University, and the University of Wisconsin, and NIH-funded postdoctoral training in clinical research.

Her assessment work centers on differential questions in adults — distinguishing anxiety and depression from medical, medication-related, and cognitive contributors, and clarifying what is driving a presentation before a treatment plan is built around it. She reviews every clinical article published by ScienceWorks for accuracy.

References

1. Johnco CJ, Matovic D, Wuthrich VM. Anxiety disorders in later life. Psychiatr Clin North Am. 2024;47(4):741-752. https://pubmed.ncbi.nlm.nih.gov/39505451/

2. Shafiee A, Mohammadi I, Rajai S, Jafarabady K, et al. Global prevalence of anxiety symptoms and its associated factors in older adults: a systematic review and meta-analysis. J Gen Fam Med. 2025;26(2):116-127. https://pubmed.ncbi.nlm.nih.gov/40061394/

3. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. https://pubmed.ncbi.nlm.nih.gov/16717171/

4. Wild B, Eckl A, Herzog W, Niehoff D, et al. Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. Am J Geriatr Psychiatry. 2014;22(10):1029-1038. https://pubmed.ncbi.nlm.nih.gov/23768681/

5. Pachana NA, Byrne GJ, Siddle H, Koloski N, et al. Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr. 2007;19(1):103-114. https://pubmed.ncbi.nlm.nih.gov/16805925/

6. Hill NL, Mogle J, Bell TR, Bhargava S, et al. Predicting current and future anxiety symptoms in cognitively intact older adults with memory complaints. Int J Geriatr Psychiatry. 2019;34(12):1874-1882. https://pubmed.ncbi.nlm.nih.gov/31468598/

7. Johnco CJ, Dickson SJ, Seaton A. A systematic review and meta-analysis of diagnostic remission, treatment response, attrition and relapse following cognitive behavior therapy (CBT), other psychological therapies and pharmacological treatments for anxiety disorders in older adults. Am J Geriatr Psychiatry. 2026;34(4):500-521. https://pubmed.ncbi.nlm.nih.gov/40581526/

8. Stanley MA, Wilson NL, Novy DM, Rhoades HM, et al. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: a randomized clinical trial. JAMA. 2009;301(14):1460-1467. https://pubmed.ncbi.nlm.nih.gov/19351943/

9. Gould RL, Coulson MC, Howard RJ. Efficacy of cognitive behavioral therapy for anxiety disorders in older people: a meta-analysis and meta-regression of randomized controlled trials. J Am Geriatr Soc. 2012;60(2):218-229. https://pubmed.ncbi.nlm.nih.gov/22283717/

10. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. NICE guideline CG113. https://www.nice.org.uk/guidance/cg113

Disclaimer

This article is for informational purposes only and is not a substitute for individualized clinical advice, diagnosis, or treatment. Reading it does not create a clinician-patient relationship. If you are concerned about your mental health, please consult a qualified professional.